Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma

Abstract

The SIS as a potentially powerful prognostic biomarker might improve traditional clinicopathological analysis to refine clinical outcome prediction for ccRCC patients after surgery.